Alerts will be sent to your verified email
Verify Email
VENUSREM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Venus Remedies Limited is an Indian pharmaceutical company with a global presence, specializing in critical care and super specialty segments. It is dedicated to research, innovation, and delivering high-quality products worldwide.
Venus Remedies major competitors are Sakar Healthcare, Jagsonpal Pharma, Syncom Formulations, Kwality Pharma, Ind-Swift Lab., Lincoln Pharma, Beta Drugs.
Market Cap of Venus Remedies is ₹1,438 Crs.
While the median market cap of its peers are ₹1,297 Crs.
Venus Remedies seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Mar Sep | Mar Sep Dec | |||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
